Amgen

Open: 229.03 Close: 228.77 Change: -0.26

The unbelievably easy way to evaluate Amgen Company Inc: Use an AI.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, previous, move, stock, AMGN, condition, discus, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (AMGN) closed at $229.66 in the latest trading session, marking a +0.53% move from the previous day. Amgen revenue was $26.32 billion, an increase of 1.32% compared to the previous years $25.98 billion.

Today's News

Amgen Inc. makes money by creating treatments for medical conditions affecting millions. Amgen is one of the worlds largest independent biotechnology companies. Amgen to present at Goldman Sachs 44th Annual Global Healthcare Conference at 2:20 p.m. Analyst Consensus: Hold Stock Forecasts. Amgen revenue was $26.32 billion, an increase of 1.32% compared to the previous years $25.98 billion. Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the sharp decline of Horizon Therapeutics shares after a report surfaced that the FTC is planning to sue to block Amgens $28 billion deal. Jefferies managing director Michael Yee, Jefferies Managing Director, joins Power Lunch to discuss the FTCs move. Amgen is a developer of pharmaceutical products for treating multiple diseases. Amgen ranks 7 th among 1,694 competitors. Amgen - amgn - stock price today - zacks Is It Time to Buy AMGN? Shares are down today. amgen pledges not to bundle horizon products in response to ftc anti-trust suit. Amgen Retirement and Savings Plan provides for investment options representing varied investment options. Plan participants can invest in seven different asset classes as well as Amgen stock. Participants may direct a maximum of 20% of contributions to be invested in Amgenstock. Amgen (AMGN) closed at $229.66 in the latest trading session, marking a +0.53% move from the previous day. Amgen produces drugs to treat several conditions and markets them worldwide. Amgen (AMGN) closed at $229.66 in the latest trading session, marking a +0.53% move from the previous day. Amgen rose more than any other stock, but Intel led the index lower.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, previous, move, stock, AMGN, condition, discus, and the most common words in the summary are: amgen, stock, market, news, fund, index, option, . One of the sentences in the summary was: Amgen revenue was $26.32 billion, an increase of 1.32% compared to the previous years $25.98 billion.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #news #fund #index #option.